Statin Use in Patients With Extremely Low Low-Density Lipoprotein Levels Is Associated With Improved Survival | Zendy

Nicholas J. Leeper | Zendy; Reza Ardehali | Zendy; Emil M. deGoma | Zendy; Paul A. Heidenreich | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Statin Use in Patients With Extremely Low Low-Density Lipoprotein Levels Is Associated With Improved Survival

Author(s) -

Nicholas J. Leeper,

Reza Ardehali,

Emil M. deGoma,

Paul A. Heidenreich

Publication year - 2007

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.107.694117

Subject(s) - medicine , statin , hazard ratio , medical prescription , diabetes mellitus , proportional hazards model , propensity score matching , confidence interval , endocrinology , pharmacology

Aggressive lipid management has recently become the standard of care for patients with coronary heart disease. The safety and effectiveness of statin usage for patients with extremely low low-density lipoprotein (LDL) levels are less clear, however. The aim of this study was to investigate the safety and clinical outcomes of statin treatment in patients with LDL cholesterol levels below 60 mg/dL.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research